Evidence map›Paper›PMID 30173372›Full record

ArticleMolecular and cellular biochemistry2019

TDCPP protects cardiomyocytes from H

Weishan Zhang, Xin Hou, Mengjun Huang, Xixi Zeng, Xiju He, Yanhong Liao

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Weishan ZhangDepartment of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Xin HouDepartment of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Mengjun HuangDepartment of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Xixi ZengDepartment of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Xiju HeDepartment of Anatomy, Hubei University of Medicine, Shiyan, 442000, Hubei, China. huizi630@163.com.
Yanhong LiaoDepartment of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China. yhliao1@hust.edu.cn.ORCID http://orcid.org/0000-0001-6308-3120
Huazhong University of Science and Technology · CNHubei University of Medicine · CN

Funding

National Natural Science Foundation of China 30970662Natural Science Foundation of Hubei Province 2018CFB668
6 · The paper itself

Abstract

Tris (1, 3-dichloro-2-propyl) phosphate (TDCPP) is a major type of organophosphorus flame retardants, and long-term exposure to TDCPP to normal cells or tissues under physiological conditions can induce toxic effects. But how TDCPP leads to the adverse effects is not yet clear, and the effect of TDCPP under pathological conditions such as reactive oxygen species assault is not well understood. The present study aimed to explore the potential effect of TDCPP against H

Indexed as

AnimalsCalciumCalcium SignalingCell LineGlycogen Synthase Kinase 3 betaHumansHydrogen PeroxideMiceMyocytes, CardiacOrganophosphorus CompoundsOxidative StressPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktRatsCalciumGlycogen Synthase Kinase 3 betaGsk3b protein, ratHydrogen PeroxideOrganophosphorus CompoundsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akttris(1,3-dichloro-2-propyl)phosphateApoptosisCalcium overloadCardiomyocytesOxidative stressTDCPP

Identifiers

PMID30173372
OpenAlexW2889081996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.